124 related articles for article (PubMed ID: 25519686)
41. A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy.
Cardone RA; Greco MR; Zeeberg K; Zaccagnino A; Saccomano M; Bellizzi A; Bruns P; Menga M; Pilarsky C; Schwab A; Alves F; Kalthoff H; Casavola V; Reshkin SJ
Neoplasia; 2015 Feb; 17(2):155-66. PubMed ID: 25748234
[TBL] [Abstract][Full Text] [Related]
42. FSCN1 and epithelial mesenchymal transformation transcription factor expression in human pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Morris HT; Bamlet WR; Razidlo GL; Machesky LM
Pathol Res Pract; 2023 Nov; 251():154836. PubMed ID: 37832352
[TBL] [Abstract][Full Text] [Related]
43. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice: effects of alcohol and caffeine.
Wendt LR; Osvaldt AB; Bersch VP; Schumacher Rde C; Edelweiss MI; Rohde L
Acta Cir Bras; 2007; 22(3):202-9. PubMed ID: 17546293
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors.
Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T
J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145
[TBL] [Abstract][Full Text] [Related]
45. PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.
Sinha S; Fu YY; Grimont A; Ketcham M; Lafaro K; Saglimbeni JA; Askan G; Bailey JM; Melchor JP; Zhong Y; Joo MG; Grbovic-Huezo O; Yang IH; Basturk O; Baker L; Park Y; Kurtz RC; Tuveson D; Leach SD; Pasricha PJ
Cancer Res; 2017 Apr; 77(8):1868-1879. PubMed ID: 28386018
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
47. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma.
Krah NM; De La O JP; Swift GH; Hoang CQ; Willet SG; Chen Pan F; Cash GM; Bronner MP; Wright CV; MacDonald RJ; Murtaugh LC
Elife; 2015 Jul; 4():. PubMed ID: 26151762
[TBL] [Abstract][Full Text] [Related]
48. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
49. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
[TBL] [Abstract][Full Text] [Related]
50. Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancreatic Cancer.
Yazawa K; Nakamura F; Masukawa D; Sato S; Hiroshima Y; Yabushita Y; Mori R; Matsuyama R; Kato I; Taniguchi H; Goshima Y; Endo I
Transl Oncol; 2020 Mar; 13(3):100746. PubMed ID: 32105991
[TBL] [Abstract][Full Text] [Related]
51. PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug.
Wang C; Yang A; Zhang B; Yin Q; Huang H; Chen M; Xie J
Pancreas; 2014 Mar; 43(2):291-7. PubMed ID: 24518510
[TBL] [Abstract][Full Text] [Related]
52. The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
Veite-Schmahl MJ; Rivers AC; Regan DP; Kennedy MA
PLoS One; 2017; 12(11):e0187552. PubMed ID: 29121082
[TBL] [Abstract][Full Text] [Related]
53. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
[TBL] [Abstract][Full Text] [Related]
54. Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.
Garcia-Carracedo D; Yu CC; Akhavan N; Fine SA; Schönleben F; Maehara N; Karg DC; Xie C; Qiu W; Fine RL; Remotti HE; Su GH
PLoS One; 2015; 10(3):e0120851. PubMed ID: 25803032
[TBL] [Abstract][Full Text] [Related]
55. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.
Lesina M; Kurkowski MU; Ludes K; Rose-John S; Treiber M; Klöppel G; Yoshimura A; Reindl W; Sipos B; Akira S; Schmid RM; Algül H
Cancer Cell; 2011 Apr; 19(4):456-69. PubMed ID: 21481788
[TBL] [Abstract][Full Text] [Related]
56. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
[TBL] [Abstract][Full Text] [Related]
57. Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma.
Muslimov GF
Bull Exp Biol Med; 2008 Apr; 145(4):535-8. PubMed ID: 19110611
[TBL] [Abstract][Full Text] [Related]
58. Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer.
Meyer KA; Neeley CK; Baker NA; Washabaugh AR; Flesher CG; Nelson BS; Frankel TL; Lumeng CN; Lyssiotis CA; Wynn ML; Rhim AD; O'Rourke RW
Biochem Biophys Rep; 2016 Sep; 7():144-149. PubMed ID: 27617308
[TBL] [Abstract][Full Text] [Related]
59. Changes in the Expression of Glucose-regulated Protein 78 in the Occurrence and Progression of Pancreatic Cancer in Mouse Models.
Niu ZY; Liu QF; Wang MY; Zhou L; Yao LT; Liao Q; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Jun; 37(3):259-63. PubMed ID: 26149133
[TBL] [Abstract][Full Text] [Related]
60. NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.
Schmahl MJ; Regan DP; Rivers AC; Joesten WC; Kennedy MA
PLoS One; 2018; 13(7):e0200658. PubMed ID: 30016349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
